Blood test may predict cancer spread in women

NCT ID NCT04817501

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at whether a simple blood test (liquid biopsy) can help track breast, ovarian, and endometrial cancers. Researchers analyzed circulating tumor cells in 150 women to see if these cells could predict the risk of cancer spreading or how well treatment works. The goal is to develop a less invasive way to monitor these cancers over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to help predict cancer spread and monitor treatment effectiveness in female reproductive cancers.

What could go wrong

This is an observational study, not a treatment trial. The findings are early and may not translate into a reliable clinical test without further validation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm endometrial cancer endometrium neoplasm Neoplastic Cells, Circulating ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Evgeniya Kaigorodova

    Tomsk, Tomsk Oblast, 634050, Russia